News | Proton Therapy | December 17, 2015

St. Jude Children's Research Hospital Opens New Proton Therapy Center

First proton center fully dedicated to pediatric cancer will feature Hitachi system with spot scanning irradiation technology

Hitachi, St. Jude Children's Research Hospital, Red Frog Events Proton Therapy Center

December 17, 2015 — Hitachi Ltd. announced that St. Jude Children’s Research Hospital opened the St. Jude Red Frog Events Proton Therapy Center in Memphis, Tennessee, the world’s first proton therapy center solely dedicated to children. The new center has 190-degree half gantries that provide efficient and spacious treatment-room environments suited specifically for pediatric care. All rooms are equipped with spot-scanning irradiation, a technology for which Hitachi received the first U.S. Food and Drug Administration (FDA) Premarket Notification Special 510(k) clearance in 2007.

St. Jude will be Hitachi’s third proton therapy site in the United States.

“The opening of the St. Jude Red Frog Events Proton Therapy Center marks an important step in our efforts to provide therapies that maximize cures while minimizing long-term treatment complications,” said James R. Downing, M.D., St. Jude president and chief executive officer. “The center is an engineering marvel made possible through the talents of many who are committed to offering children with cancer the best hope for the future.”

Radiation therapy, used alone or in combination with surgery and chemotherapy, is an integral component for successfully managing and treating pediatric tumors. Proton therapy allows doctors to administer targeted, high-dose radiation while sparing surrounding healthy tissue from exposure.

Proton beam therapy is an advanced form of external beam radiotherapy in which the protons from a hydrogen atom are extracted and accelerated up to 70 percent the speed of light. The energy beam is concentrated directly on the tumor, minimizing radiation doses to the surrounding healthy tissues. The procedure has fewer side effects compared to traditional radiotherapy.

Spot-scanning irradiation technology does not scatter proton beams like conventional proton beam therapy does. Rather, it repeatedly turns a narrow proton beam on and off at high speed as it progressively changes location to irradiate entire tumor volumes. Protons can be aimed with high precision at targeted tumors, even those with complex shapes, while minimizing the impact on nearby healthy tissue.

For more information: www.hitachi.com

Related Content

FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S.
Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning
News | Treatment Planning | January 31, 2019
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc.